TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bionord Biokemi AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
66,260
|
65,966
|
51,801 |
Financial expenses |
2
|
9
|
20 |
Earnings before taxes |
7,134
|
6,777
|
6,539 |
EBITDA |
7,140
|
6,835
|
6,622 |
Total assets |
25,235
|
27,291
|
23,596 |
Current assets |
22,702
|
24,869
|
21,039 |
Current liabilities |
7,321
|
11,390
|
8,599 |
Equity capital |
15,165
|
13,528
|
12,772 |
- share capital |
507
|
473
|
488 |
Employees (average) |
6
|
5
![]() |
5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
60.1%
|
49.6%
|
54.1% |
Turnover per employee |
11,043
|
13,193
|
10,360 |
Profit as a percentage of turnover |
10.8%
|
10.3%
|
12.6% |
Return on assets (ROA) |
28.3%
|
24.9%
|
27.8% |
Current ratio |
310.1%
|
218.3%
|
244.7% |
Return on equity (ROE) |
47.0%
|
50.1%
|
51.2% |
Change turnover |
-4,386
|
15,722
|
-4,959 |
Change turnover % |
-6%
|
31%
|
-9% |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
20%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.